VanEck Fabless Semiconductor ETF (NASDAQ: SMHX)

最新ニュース VanEck Fabless Semiconductor ETF (NASDAQ:SMHX)

The Fund normally invests at least 80% of its total assets in securities that comprise the Funds benchmark index. The Fabless Index is composed of U.S.-listed common stocks of companies that derive at least 50% of their revenues from the semiconductor industry and operate as fabless semiconductor companies. A fabless semiconductor company is generally defined as an advanced chip designer without a production line. More specifically, a fabless semiconductor company is engaged in the design and sale of semiconductors and hardware while outsourcing most semiconductor fabrication and product manufacturing. Furthermore, the Fabless Index does not currently include companies engaged in the production of equipment used in the manufacturing of semiconductors or semiconductor materials used in visual displays

VanEck Fabless Semiconductor ETF

Deep-pocketed investors have adopted a bullish approach towards Summit Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SMMT usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Summit Therapeutics. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 54% leaning bullish and 45% bearish. Among these notable options, 5 are puts, totaling $1,143,532, and 6 are calls, amounting to $974,684.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $10.0 to $17.0 for Summit Therapeutics over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of Summit Therapeutics stands at 493.25, with a total volume reaching 8,490.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Summit Therapeutics, situated within the strike price corridor from $10.0 to $17.0, throughout the last 30 days.
<h3>Summit Therapeutics 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740689180_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SMMT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$4.2</td>
<td>$3.1</td>
<td>$4.0</td>
<td>$17.00</td>
<td>$606.8K</td>
<td align="right">179</td>
<td>2.7K</td>
</tr>
<tr>
<td>SMMT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$10.1</td>
<td>$9.8</td>
<td>$10.1</td>
<td>$10.00</td>
<td>$264.6K</td>
<td align="right">42</td>
<td>949</td>
</tr>
<tr>
<td>SMMT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$10.2</td>
<td>$10.1</td>
<td>$10.1</td>
<td>$10.00</td>
<td>$227.2K</td>
<td align="right">42</td>
<td>467</td>
</tr>
<tr>
<td>SMMT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$3.9</td>
<td>$3.0</td>
<td>$3.9</td>
<td>$17.00</td>
<td>$190.7K</td>
<td align="right">179</td>
<td>750</td>
</tr>
<tr>
<td>SMMT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$4.0</td>
<td>$3.9</td>
<td>$3.9</td>
<td>$17.00</td>
<td>$187.9K</td>
<td align="right">179</td>
<td>1.2K</td>
</tr>
</tbody>
</table>

<h3>About Summit Therapeutics</h3>
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
After a thorough review of the options trading surrounding Summit Therapeutics, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Summit Therapeutics</h3>
<ul>
<li>With a trading volume of 1,519,830, the price of SMMT is up by 3.88%, reaching $19.01.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 62 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Summit Therapeutics</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $38.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from HC Wainwright &amp; Co. downgraded its action to Buy with a price target of $44. 
&#x2A; Reflecting concerns, an analyst from Citizens Capital Markets lowers its rating to Market Outperform with a new price target of $32.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Summit Therapeutics options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

Markets

SMMT

Summit Therapeutics's Options Frenzy: What You Need to Know

High-rolling investors have positioned themselves bullish on Madrigal Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDGL#NASDAQ">MDGL</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in MDGL often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 9 options trades for Madrigal Pharmaceuticals. This is not a typical pattern.
The sentiment among these major traders is split, with 44% bullish and 44% bearish. Among all the options we identified, there was one put, amounting to $50,600, and 8 calls, totaling $2,289,644.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $200.0 to $380.0 for Madrigal Pharmaceuticals over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Madrigal Pharmaceuticals stands at 337.17, with a total volume reaching 507.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Madrigal Pharmaceuticals, situated within the strike price corridor from $200.0 to $380.0, throughout the last 30 days.
<h3>Madrigal Pharmaceuticals Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740689174_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MDGL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$66.0</td>
<td>$65.0</td>
<td>$65.0</td>
<td>$320.00</td>
<td>$1.3M</td>
<td>1.5K</td>
<td align="right">300</td>
</tr>
<tr>
<td>MDGL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$73.8</td>
<td>$72.8</td>
<td>$72.8</td>
<td>$320.00</td>
<td>$728.0K</td>
<td>1.5K</td>
<td align="right">100</td>
</tr>
<tr>
<td>MDGL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$182.0</td>
<td>$175.0</td>
<td>$175.0</td>
<td>$200.00</td>
<td>$70.0K</td>
<td>1</td>
<td align="right">4</td>
</tr>
<tr>
<td>MDGL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$69.9</td>
<td>$68.4</td>
<td>$68.4</td>
<td>$380.00</td>
<td>$68.4K</td>
<td>4</td>
<td align="right">0</td>
</tr>
<tr>
<td>MDGL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$25.0</td>
<td>$19.5</td>
<td>$23.0</td>
<td>$340.00</td>
<td>$50.6K</td>
<td>31</td>
<td align="right">22</td>
</tr>
</tbody>
</table>

<h3>About Madrigal Pharmaceuticals</h3>
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
After a thorough review of the options trading surrounding Madrigal Pharmaceuticals, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Madrigal Pharmaceuticals</h3>
<ul>
<li>With a volume of 357,841, the price of MDGL is down -4.98% at $338.15. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 68 days.</li>
</ul>
<h3>Expert Opinions on Madrigal Pharmaceuticals</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $437.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on Madrigal Pharmaceuticals with a target price of $469. 
&#x2A; An analyst from HC Wainwright &amp; Co. persists with their Buy rating on Madrigal Pharmaceuticals, maintaining a target price of $405. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Madrigal Pharmaceuticals, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

MDGL

Decoding Madrigal Pharmaceuticals's Options Activity: What's the Big Picture?

Investors with significant funds have taken a bullish position in TJX Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TJX#NYSE">TJX</a>), a development that retail traders should be aware of.
This was brought to our attention today through our monitoring of publicly accessible options data at Benzinga. The exact nature of these investors remains a mystery, but such a major move in TJX usually indicates foreknowledge of upcoming events.
Today, Benzinga's options scanner identified 9 options transactions for TJX Companies. This is an unusual occurrence. The sentiment among these large-scale traders is mixed, with 88% being bullish and 11% bearish. Of all the options we discovered, 8 are puts, valued at $738,098, and there was a single call, worth $28,480.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $115.0 to $126.0 for TJX Companies over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of TJX Companies stands at 433.0, with a total volume reaching 1,423.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in TJX Companies, situated within the strike price corridor from $115.0 to $126.0, throughout the last 30 days.
<h3>TJX Companies 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740689169_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TJX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$10.55</td>
<td>$10.25</td>
<td>$10.45</td>
<td>$125.00</td>
<td>$522.5K</td>
<td align="right">91</td>
<td align="right">514</td>
</tr>
<tr>
<td>TJX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/28/25</td>
<td>$2.27</td>
<td>$2.26</td>
<td>$2.26</td>
<td>$126.00</td>
<td>$39.5K</td>
<td align="right">562</td>
<td align="right">1</td>
</tr>
<tr>
<td>TJX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$7.15</td>
<td>$7.1</td>
<td>$7.1</td>
<td>$125.00</td>
<td>$31.9K</td>
<td align="right">550</td>
<td align="right">97</td>
</tr>
<tr>
<td>TJX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$7.15</td>
<td>$7.1</td>
<td>$7.1</td>
<td>$125.00</td>
<td>$31.9K</td>
<td align="right">550</td>
<td align="right">52</td>
</tr>
<tr>
<td>TJX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$3.85</td>
<td>$3.7</td>
<td>$3.7</td>
<td>$115.00</td>
<td>$29.6K</td>
<td align="right">445</td>
<td align="right">90</td>
</tr>
</tbody>
</table>

<h3>About TJX Companies</h3>
TJX Companies is the leading off-price retailer of apparel, accessories, and home merchandise in the United States. The firm leverages its more than 20,000 global vendor relationships to procure and sell brand-name merchandise at prices 20%-60% cheaper than conventional retail channels. TJX opportunistically purchases excess inventory that stems from manufacturing overruns and retail closeout sales. The off-price retailer disperses its vast and disparate merchandise across its 5,000 global stores, creating a treasure-hunt shopping experience for consumers. Over three quarters of TJX's sales are derived from the United States, primarily via the T.J. Maxx, Marshalls, and HomeGoods banners. About 10% of sales are from Canada and 12% from Europe and Australia.
In light of the recent options history for TJX Companies, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is TJX Companies Standing Right Now?</h3>
<ul>
<li>With a trading volume of 3,445,662, the price of TJX is down by -0.93%, reaching $123.72.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 83 days from now.</li>
</ul>
<h3>Expert Opinions on TJX Companies</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $142.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from BMO Capital keeps a Outperform rating on TJX Companies with a target price of $145. 
&#x2A; Consistent in their evaluation, an analyst from Telsey Advisory Group keeps a Outperform rating on TJX Companies with a target price of $145. 
&#x2A; An analyst from Baird has decided to maintain their Outperform rating on TJX Companies, which currently sits at a price target of $140. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on TJX Companies with a target price of $137. 
&#x2A; An analyst from Telsey Advisory Group persists with their Outperform rating on TJX Companies, maintaining a target price of $145. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for TJX Companies, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Market Whales and Their Recent Bets on TJX Options

The Garden State&#8217;s cannabis industry will take center stage at the upcoming <a href="https://cannabismarketspotlight.com/new-jersey/#about">Benzinga Cannabis Market Spotlight</a> on March 4, 2025, at the Delta Hotels by Marriott in Somerset. This event aims to delve into New Jersey&#8216;s burgeoning cannabis market, offering insights into retail opportunities, supply chain logistics, and regulatory frameworks.
<h3 class="wp-block-heading">A Brief History of Cannabis Legalization in New Jersey</h3>
New Jersey&#8217;s journey with cannabis reform began in 2010 when the state legalized medical marijuana through legislative action. A significant milestone was achieved on Feb. 22, 2021, when Governor Phil Murphy signed the New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act into law, legalizing cannabis use and possession for adults aged 21 and over.
This move followed a 2020 ballot referendum where New Jerseyans overwhelmingly supported legalization. The first recreational cannabis sales commenced on April 21, 2022, marking the state&#8217;s full entry into the regulated cannabis market.
<h3 class="wp-block-heading">Recent Developments in New Jersey&#8217;s Cannabis Industry</h3>
The state&#8217;s cannabis market has experienced robust growth, surpassing $1 billion in combined medicinal and recreational sales in 2024—a nearly 25% increase from the previous year&#8217;s total.
However, the industry faces challenges. In December 2024, the New Jersey Cannabis Regulatory Commission approved an increase in the Social Equity Excise Fee (SEEF) by $1.26 per ounce, effective Jan. 1, 2025. This fee aims to fund social equity programs within the state.
Additionally, the state has taken steps to regulate hemp-derived THC products. In November 2024, New Jersey authorities announced enforcement of a ban on hemp products containing THC or derivatives that are &#8220;not naturally occurring,&#8221; addressing concerns over unregulated products entering the market.
<h3 class="wp-block-heading">Benzinga Cannabis Market Spotlight: What to Expect</h3>
The upcoming Benzinga event will feature diverse speakers, including industry leaders, entrepreneurs, and policymakers. Notable participants include Dianna Houenou, commission chair of the New Jersey Cannabis Regulatory Commission, and Christopher Riggs, its acting executive director. Discussions will cover strategies for transitioning the illicit market to a regulated framework, navigating New Jersey&#8217;s regulatory landscape, and exploring the role of cannabis lounges as unique tourism attractions near New York City.
As New Jersey continues to cultivate its cannabis industry, events like the <a href="https://cannabismarketspotlight.com/new-jersey/#about">Benzinga Cannabis Market Spotlight</a> provide a platform for stakeholders to engage, collaborate, and shape the future of cannabis in the state and beyond. <a href="https://cannabismarketspotlight.com/new-jersey/#about">Make sure to secure tickets today.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/44018198/cronos-q4-sales-jump-27-on-higher-cannabis-flower-and-extract-sales-reports-improved-profitability">Cronos Q4 Sales Jump 27% On Higher Cannabis Flower And Extract Sales, Reports Improved Profitability</a></li>
</ul>
Photo: Shutterstock

Cannabis

Events

General

New Jersey's Cannabis Market Thrives: $1 Billion In Sales, Policy Shifts, Industry Insights At Benzinga Event

Abercrombie &amp; Fitch (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) has outperformed the market over the past 10 years by 6.69% on an annualized basis producing an average annual return of 17.49%. Currently, Abercrombie &amp; Fitch has a market capitalization of $5.30 billion. 
Buying $100 In ANF: If an investor had bought $100 of ANF stock 10 years ago, it would be worth $423.63 today based on a price of $105.30 for ANF at the time of writing.
<h3>Abercrombie &amp; Fitch's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740689116_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

Here's How Much $100 Invested In Abercrombie & Fitch 10 Years Ago Would Be Worth Today

Apollo Global Management is negotiating to lead a $35 billion financing deal to support Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) in developing new data centers across the U.S., according to a Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-02-27/meta-in-talks-to-raise-35-billion-for-data-center-financing-led-by-apollo?srnd=homepage-americas&amp;sref=TBDibEcD">report</a>. 
What To Know: The talks are still in early stages and no final agreement has been made. Meta's broader strategy includes investing up to $65 billion this year in <a href="https://www.benzinga.com/topic/artificial-intelligence">AI-related projects</a>, including new data centers and expanding its AI workforce.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/44015322/nvidia-analyst-sees-significant-upside-for-stock-with-favorable-riskreward">Nvidia Analyst Sees &#8216;Significant Upside&#8217; For Stock With Favorable Risk/Reward</a>
As demand for AI infrastructure surges, investors and banks are eager to fund projects crucial to the ecosystem. Apollo, expanding its reach in private credit, aims to provide substantial capital to Meta, <a href="https://www.benzinga.com/tech/24/12/42321266/meta-joins-big-techs-shift-to-nuclear-power-for-ai-ambitions">which plans to boost computing power</a> by a gigawatt in 2025.
Why It Matters to Investors: The potential deal highlights opportunities in private credit, data center financing and AI infrastructure, sectors critical for growth. As AI adoption accelerates, companies like Meta will drive significant demand for data centers, creating lucrative investment avenues.
Additionally, Apollo's involvement underscores the growing influence of private credit firms in funding major tech projects, offering investors new ways to tap into the rapidly expanding AI market.
Read Next:<a href="https://www.benzinga.com/news/econ-s/25/02/43977811/mortgage-rates-drop-to-lowest-levels-since-december-but-housing-market-remains-largely-stuck" target="_blank" rel="noreferrer noopener"></a>
<ul>
<li><a href="https://www.benzinga.com/news/econ-s/25/02/43977811/mortgage-rates-drop-to-lowest-levels-since-december-but-housing-market-remains-largely-stuck" target="_blank" rel="noreferrer noopener">Mortgage Rates Drop To Lowest Levels Since December, But Housing Market Remains ‘Largely Stuck' </a></li>
</ul>
Photo: Mamun sheikh K via Shutterstock.com

Financing

Tech

Apollo Global Management In Talks To Lead $35 Billion Financing For Meta's AI Data Centers

Cryptocurrency markets are struggling on Thursday as the market-wide downturn continues.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$83,057.97</td>
<td>-0.2%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$2,268.27</td>
<td>-1.2%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>&nbsp;$134.86</td>
<td>+2.7%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>&nbsp;$2.15</td>
<td>-1.3%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.2030</td>
<td>+2.3%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00001430</td>
<td>+2.3%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume decreasing by 6.6% and daily active addresses falling by 0.7%. Transactions greater than $100,000 are down from 15,415 to 13,305 in a single day. Exchanges netflows are down by 137.5%.</li>
<li>Coinglass data reports 131,251 traders were liquidated in the past 24 hours for $404.95 million.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://in.benzinga.com/analyst-ratings/analyst-color/25/02/44012083/mara-holdings-surges-on-record-q4-revenues-analysts-weigh-in">MARA Holdings Surges On Record Q4 Revenues, Analysts Weigh In</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44010575/trump-tariff-tsunami-threatens-to-wash-away-bitcoin-bull-market-commentator-warns">Trump Tariff Tsunami Threatens To Wash Away Bitcoin Bull Market, Commentator Warns</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44010112/trump-coin-prompts-house-democrats-to-introduce-meme-act">TRUMP Coin Prompts House Democrats To Introduce MEME Act</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43996312/sec-closes-investigation-against-crypto-exchange-gemini-says-cameron-winklevoss-another-milestone-to-the-end-of-the-war-on-crypto">SEC Closes Investigation Against Crypto Exchange Gemini, Says Cameron Winklevoss: &#8216;Another Milestone To The End Of The War On Crypto&#8217; (UPDATED)</a></li>
</ul>
Top Losers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>DeXe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">DEXE</a>)</td>
<td>&nbsp;$18.05</td>
<td>-9.4%</td>
</tr>
<tr>
<td>Story (CRYPTO: IP)</td>
<td>&nbsp;$5.96</td>
<td>-9.3%</td>
</tr>
<tr>
<td>Celestia (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TIA</a>)</td>
<td>&nbsp;$3.63</td>
<td>-6.6%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Despite Bitcoin continuing to move lower, crypto chart analyst Ali Martinez says the crypto king is ready for a rebound. He cites an oversold RSI a buy signal on the TD Sequential indicator as evidence.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> looks ready for a rebound as the RSI enters oversold territory and the TD Sequential flashes a buy signal on the daily chart! <a href="https://t.co/Fqx9BLBlNc">pic.twitter.com/Fqx9BLBlNc</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1895188904351023142?ref_src=twsrc%5Etfw">February 27, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader Kevin <a href="https://x.com/Kev_Capital_TA/status/1895182692951482390">said</a> that Bitcoin is back at $84,500 after three months, but sentiment has flipped RSI dropped from 85 to 25, and the Fear &amp; Greed Index fell from 83 to 20.
Crypto trader Michael van de Poppe <a href="https://x.com/CryptoMichNL/status/1895180329339756572">stated </a>that the cycle is not over—it's just beginning. Bitcoin hasn't reached euphoria yet, and he expects it to surpass $200,000-$250,000 this cycle. 
More Crypto Online <a href="https://x.com/Morecryptoonl/status/1895174928766509179">sees</a> Bitcoin testing support at $83,219. If it holds, a (C)-wave rally into resistance for circle wave 4 is expected.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a>: The price is currently testing wave (B)/(2) support. As long as the price holds above $83,219, I expect at least a (C)-wave rally into resistance for circle wave 4.<a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> <a href="https://t.co/Xih4KIlg12">pic.twitter.com/Xih4KIlg12</a>
&mdash; More Crypto Online (@Morecryptoonl) <a href="https://twitter.com/Morecryptoonl/status/1895174928766509179?ref_src=twsrc%5Etfw">February 27, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44016927/bitcoin-drops-below-85000-what-does-technical-analysis-say">Bitcoin Drops Below $85,000: What Does Technical Analysis Say?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DEXE

$DOGE

$ETH

$SHIB

$SOL

$TIA

$XRP

Bitcoin, Ethereum, XRP, Dogecoin Struggle In Weak Market: 'I Don't Think That The Cycle Is Over,' Trader Says

WIIM

BIRK

BURL

ETSY

EVGO

FIVE

LULU

PLCE

ULTA

Shares of e-commerce and retail companies are trading lower amid weakening consumer confidence and eBay's soft Q1 revenue guidance.

MSFT

Microsoft Introduces GPT-4.5 In Preview On Azure OpenAI Service

After a subdued response to AI chip giant NVDIA&#8217;s earnings on Wednesday night, it&#8217;s clear that traders are willing to keep stock prices in a range while the new administration&#8217;s changes continue to unfold in Washington D.C.
So, with memory chip-maker Micron&#8217;s earnings coming in the next few weeks, we can expect the same reaction.
A short iron condor trade is the way to take advantage and generate some income.&nbsp;
Micron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), which scores high on Benzinga Edge&#8217;s Growth and Quality rankings but has middling Momentum and Value, has been range bound since August, 2024. The range is tightening but the use of weekly contracts will increase time decay in our favor.
The stock&#8217;s resistance sits just above $105 but has rejected this line within days of touching. Support sits near $85 which has also been a favorable buying opportunity for traders with a bullish slant.&nbsp;
The way we trade this is with a short iron condor.
<h2 class="wp-block-heading">Understanding the short iron condor&nbsp;</h2>
A short iron condor consists of a short call spread and a short put spread combined to deliver higher income generation while the stock sits inside a channel.&nbsp;
When we position with short iron condors, we attempt to collect time decay while a chart bases or settles into a new direction. As always, we assume that we don't know the direction but are able to estimate the magnitude of the move using the ATR (average true range, measured on the weekly chart) and the implied moves that the market makers have priced into the move over the months ahead.&nbsp;
For this Micron setup, the short iron condor is:
<ul>
<li>Sell to open 1 MU 28 Mar 105 calls&nbsp;</li>
<li>Buy to open 1 MU 28 Mar 115 calls&nbsp;</li>
<li>Sell to open 1 MU 28 Mar 85 puts&nbsp;</li>
<li>Buy to open 1 MU 28 Mar 75 puts&nbsp;</li>
</ul>
At this writing the credit received is $3.90. This represents the maximum profit we will collect. With this kind of position, we collect a premium and as this premium erodes, we collect revenue from the position.&nbsp;
Our maximum exposure is calculated the following way: the distance between the spread ($10) less the collected premium ($3.90) = $6.10.
<h2 class="wp-block-heading">Understanding the short iron condor spreads&nbsp;</h2>
I often get asked why someone should take a trade where the risk is higher than the potential reward. The answer is this: the probability of the short iron condor with strikes far out of the money (meaning far away from the current price of the stock) returning gains is often as much as nine times more likely than the long iron condor.
In the current case, this is what we are looking at – the probability that the short iron condor delivering gains is more than five times as likely. So, we make the trade on the side of probabilities, rather than the possibility of outsized gains.&nbsp;
The strategy result provides three choices to exit the trade:&nbsp;
<ol>
<li>To buy back the short iron condor once it gets to an acceptable profit margin for you. I customarily look for 50% to 70% profit for these kinds of trades.&nbsp;</li>
<li>To buy back the iron condor once it hits your loss threshold as determined by personal risk- this will happen with extreme movement. I customarily look at about 30% though depending on my size, I will choose 50%.</li>
<li>To hold the iron condor into expiration week before covering – this is a choice I would rarely recommend as prices can move quickly against you. And we have earnings scheduled for 3/20 and I would prefer to exit prior to the news if I take this kind of trade.</li>
</ol>
<a href="https://www.benzinga.com/premium/ideas/benzinga-edge/?el=ResearchDaily&amp;he={{email}}&amp;adt_ei={{email}}&amp;utm_adType=SponsorAd&amp;utm_ad=RD0228&amp;utm_campaign=wallstreetadvantage">Institutional Moves. Hidden Signals. Breakout Stocks.</a>
Big-money traders leave clues, and the Whisper Index deciphers them to uncover stocks ready to run. Our system flagged Uber, Sprouts, and Insmed before their big moves—now, five new names are coming this Friday. Get ahead of Wall Street's next trade before it's too late. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge/?el=ResearchDaily&amp;he={{email}}&amp;adt_ei={{email}}&amp;utm_adType=SponsorAd&amp;utm_ad=RD0228&amp;utm_campaign=wallstreetadvantage">See My Stocks First</a>
Image via Shutterstock

Opinion

Make This Income Trade as Chip Stocks Tumble

Bitcoin is trading lower. Weakness may be due to lower risk sentiment amid overall market concerns.

Chances are, a cursory look at the financial publication ecosystem will reveal that mobile technology specialist AppLovin Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) is a fantastic discounted opportunity. Due <a href="https://www.benzinga.com/trading-ideas/movers/25/02/43981217/applovin-stock-drops-on-multiple-short-reports-allegations-of-copying-meta-creating-smoke-and-mirrors-game">to multiple short-seller attacks</a>, APP stock finds itself down around 26% in the past five sessions. 
This extreme volatility has pushed APP's year-to-date performance into negative territory, with the stock now down 6% for the year, erasing its strong start. Still, investors may want to temper the dip-buying impulse.
To start, no questions exist regarding the dominant performance of APP stock. Over the past 52 weeks, the security returned around 450% — even with the horrific drop. However, the trouble emerged late last week when short-selling specialist The Bear Cave released a <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43856737/applovin-stock-tumbles-as-short-seller-takes-a-closer-look-at-whats-driving-enormous-gains">research report alleging ad fraud</a>.
"The Bear Cave believes AppLovin&#8217;s rapid rise — up ~750% over the last year to around 35x revenue — is fueled by low-quality revenue growth from ads that are deceptive, predatory, and at times unreadable or unclickable," the short seller remarked.
Compounding matters was that on Wednesday, another short-seller report took the high valuation of APP stock to task. In the latest round, Fuzzy Panda Research accused AppLovin of stealing Meta Platforms Inc.&#8216;s data, among other claims.
It's important to recognize that AppLovin CEO Adam Foroughi issued a letter to the company's shareholders, partners and team <a href="https://www.applovin.com/blog/note-from-our-ceo/">responding</a> to the short-seller allegations. While Foroughi denies that AppLovin has the capability to reverse engineer Meta's ad data, some investors may be dissatisfied with the CEO's other rebuttals.
Arguably, the most damaging accusation relates to the issue of direct downloads, a matter which Culper Research — another short-selling specialist — shared with Fuzzy Panda. Foroughi stated that "[e]very download results from an explicit user choice." However, the CEO did not provide a rigorous defense of the core allegation of "silent installs."
<h2 class="wp-block-heading">APP Stock Faces a Historically Tough Road Ahead</h2>
To be sure, it's easy to understand why the retail crowd may view APP stock as a back-up-the-truck opportunity. Relative to its Valentine's Day closing price of $510.13, APP trades hands at about a 35% haircut. However, if the core allegations stick, the company would likely require a valuation adjustment.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="583" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/27144635/APP-stock-technical-chart-1024x583.jpg" alt="" class="wp-image-802342" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/27144635/APP-stock-technical-chart-1024x583.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/27144635/APP-stock-technical-chart-300x171.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/27144635/APP-stock-technical-chart-768x437.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/27144635/APP-stock-technical-chart.jpg 1048w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Image by TradingView</figcaption></figure>
Technically speaking, APP stock is treading in dangerous waters. Throughout this year, the security's 50-day moving average provided support. However, the combined short-seller attacks have driven sentiment below this critical barometer. Now, it's sandwiched between the 50 DMA at the top and the 200 DMA at the bottom (around $195).
Still, the statistical backdrop may be the most ominous warning sign. Under ordinary circumstances, APP stock enjoys an upward bias. Further, evidence shows that investors buy the dips — to a point. However, when extreme volatility suddenly emerges, the market tends to run away.
Using data extending back to its public market debut, a position entered at the beginning of the week has a 52.48% chance of rising by the end of it. Over an eight-week period, this baseline probability rises to 61.03%.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/27143810/APP-stock-probability-gambit-1024x576.jpg" alt="" class="wp-image-802324" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/27143810/APP-stock-probability-gambit-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/27143810/APP-stock-probability-gambit-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/27143810/APP-stock-probability-gambit-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/27143810/APP-stock-probability-gambit.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Image by author</figcaption></figure>
However, under dynamic conditions of extreme volatility, the stats don't look so inviting. Following a one-week loss of 15% or greater, the long odds in the subsequent week drop to 14.29%. Over an eight-week period, the dynamic probability does improve, but only to 28.57%.
In full transparency, there have only been seven instances when APP stock has incurred a 15%-plus weekly loss. Therefore, investors must consider the risk of distortion related to small datasets. Nevertheless, the combination of short-seller research, an arguably unconvincing response and weak technical data appears to bolster the statistical case against APP.
Also Read: <a href="https://www.benzinga.com/25/02/44021519/capital-one-berkshire-hathaway-rocket-companies-shares-move-higher-after-cfpb-drops-lawsuits">Capital One, Berkshire Hathaway, Rocket Companies Shares Move Higher After CFPB Drops Lawsuits</a>
<h2 class="wp-block-heading">Why AppLovin Faces More Downside Risk</h2>
Going back to the statistical framework, the issue is not just the likelihood of poor long-side trades; rather, it's that the projected range of price outcomes conspicuously tilts downward relative to the expected range of price outcomes under baseline conditions.
Using the market intelligence above and assuming the negative scenario wins out, APP stock runs the risk of incurring a median loss of 16.98% over the next three weeks. That would put a downside target of $273.98, assuming that APP finishes this week at $330.
For an aggressive trade with some margin for error, traders may consider the 310/300 bear put spread for the options chain expiring March 21. This transaction calls for buying the $310 put (at an ask of $2,070) and simultaneously selling the $300 put (at a bid of $1,600).
The trader would use the proceeds from the short put sale to partially offset the debit of the long put, resulting in a net debit paid of $470. If APP stock falls to or below the short put strike of $300 at expiration, the trader would collect $530 or a payout of almost 113%.
A much more aggressive trade — albeit with a cheaper net debit — is the 305/300 bear put spread expiring one week earlier on March 14. This transaction requires a cash outlay of $240 for the chance to earn $260, resulting in a 108.3% payout.
Choosing an expiration period is a speculative balancing act. While a longer period is "safer" in the sense that it gives more time for the directional thesis to pan out, if the spread becomes profitable prior to the expiration, traders wanting to exit early must account for the unnecessary time value, which becomes an opportunity cost.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/02/44021377/feds-hammack-2-inflation-is-not-in-sight">Fed&#8217;s Hammack: &#8216;2% Inflation Is Not In Sight&#8217;</a></li>
</ul>
Photo: Shutterstock

Equities

Short Ideas

Options Corner: Why AppLovin May Have More To Drop Before An Eventual Recovery

Nearly one-third of Americans are delaying tax preparation this season, a decision tax professionals warn could prove costly both financially and strategically.
About 31% of taxpayers admit they&#8217;re procrastinating on filing returns, <a href="https://www.ipx1031.com/americas-biggest-tax-procrastinators-2025/">according to financial services company IPX1031</a>. The delay <a href="https://www.benzinga.com/personal-finance/24/11/42235090/callers-fiance-hasnt-filed-taxes-in-20-years-dave-ramsey-says-to-rethink-your-future-with-this-slothful-man">creates unnecessary risks</a>, particularly for the 37% of filers who rely on refunds to make ends meet.
&#8220;It&#8217;s always nice to be able to have it buttoned down early,&#8221; Ryan Losi, certified public accountant and executive vice president with Piascik, <a href="https://www.cnbc.com/2025/02/19/benefits-of-filing-taxes-early.html">told CNBC</a>. That way, you know &#8220;where you&#8217;re going to land.&#8221;
Don't Miss:
<ul>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a></li>
</ul>
Beyond financial planning, early filing reduces vulnerability to tax identity theft, where criminals file fraudulent returns to claim refunds. This form of fraud could devastate millions of Americans who depend on tax refunds for essential expenses.
Fear drives much of the procrastination, particularly among younger taxpayers. Credit Karma <a href="https://www.creditkarma.com/about/commentary/many-millennials-rely-on-tax-refund-to-make-ends-meet-tax-filing-brings-gen-z-and-self-employed-to-tears">found that 26% of Gen Z</a> procrastinators delay filing because they dread discovering what they might owe.
&#8220;If you wait to the last minute and you&#8217;re actually getting a big tax bill instead of a refund, the deadline is there, and it&#8217;s coming, and you haven&#8217;t made a plan for how you&#8217;re going to address that,&#8221; Courtney Alev, head of tax at Credit Karma, told CNBC.
Trending: <a href="https://www.benzinga.com/money/are-you-rich-2">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
Early preparation provides valuable time to develop payment strategies. &#8220;Maybe you have enough set aside to pay it,&#8221; Losi said. &#8220;But if you don&#8217;t, now you can spend the next two months saving some of your paycheck in order to pay it.&#8221;
For those expecting refunds, postponing filing means delaying access to funds that nearly half of taxpayers plan to use for debt reduction. &#8220;If you&#8217;re putting off filing, it could put some of your other goals, like paying off your credit card, at risk,&#8221; Alev cautioned.
Even taxpayers with complex financial situations benefit from early preparation. Investors awaiting brokerage statements or K-1 forms should still begin organizing their information.
See Also: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
&#8220;You want to at least have your numbers together early — then you can decide when to actually file,&#8221; Losi advised.
The Internal Revenue Service began accepting returns Jan. 27, <a href="https://www.benzinga.com/money/best-free-tax-software">giving taxpayers until April 15 to complete their filing</a>. However, tax professionals say that waiting until the deadline eliminates flexibility and potentially delays refunds that could be working for taxpayers rather than sitting interest-free with the government.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/millionaires-never-earned-six-figures-according-to-dave-ramsey">69% of Millionaires Never Earned A Six-Figure Salary – Here Are 2 Things They Do To Get Their First $1 Million, According To Dave Ramsey</a></li>
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
</ul>

Personal Finance

31% Of Americans Are Gambling With Their Tax Refund—Are You One Of Them?

Global Payments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>) has outperformed the market over the past 20 years by 2.22% on an annualized basis producing an average annual return of 10.38%. Currently, Global Payments has a market capitalization of $25.14 billion. 
Buying $1000 In GPN: If an investor had bought $1000 of GPN stock 20 years ago, it would be worth $7,160.98 today based on a price of $101.51 for GPN at the time of writing.
<h3>Global Payments's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740688234_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Global Payments Stock In The Last 20 Years

UBER

Uber shares are trading lower following a report suggesting Tesla is planning to launch a free self-driving taxi service in CA.

Investors with a lot of money to spend have taken a bearish stance on Monster Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNST#NASDAQ">MNST</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MNST, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 8 uncommon options trades for Monster Beverage.
This isn't normal.
The overall sentiment of these big-money traders is split between 25% bullish and 75%, bearish.
Out of all of the special options we uncovered, 6 are puts, for a total amount of $246,167, and 2 are calls, for a total amount of $92,779.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $45.5 to $55.0 for Monster Beverage during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Monster Beverage's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Monster Beverage's substantial trades, within a strike price spectrum from $45.5 to $55.0 over the preceding 30 days.
<h3>Monster Beverage 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740687370_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MNST</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/28/25</td>
<td>$0.8</td>
<td>$0.7</td>
<td>$0.7</td>
<td>$49.00</td>
<td>$61.0K</td>
<td align="right">340</td>
<td>3.5K</td>
</tr>
<tr>
<td>MNST</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$6.9</td>
<td>$6.6</td>
<td>$6.9</td>
<td>$55.00</td>
<td>$49.6K</td>
<td align="right">486</td>
<td>78</td>
</tr>
<tr>
<td>MNST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/28/25</td>
<td>$0.6</td>
<td>$0.55</td>
<td>$0.55</td>
<td>$55.00</td>
<td>$47.6K</td>
<td align="right">99</td>
<td>972</td>
</tr>
<tr>
<td>MNST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/07/25</td>
<td>$1.5</td>
<td>$1.45</td>
<td>$1.45</td>
<td>$53.00</td>
<td>$45.1K</td>
<td align="right">83</td>
<td>314</td>
</tr>
<tr>
<td>MNST</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/28/25</td>
<td>$1.5</td>
<td>$1.35</td>
<td>$1.5</td>
<td>$51.00</td>
<td>$40.2K</td>
<td align="right">56</td>
<td>4.8K</td>
</tr>
</tbody>
</table>

<h3>About Monster Beverage</h3>
Monster Beverage is a leader in the energy drink category within the nonalcoholic ready-to-drink beverage market, generating two thirds of revenue in the US and Canada. The well-known Monster trademark includes brands such as Monster Energy, Monster Ultra, Java Monster, and Juice Monster. The firm also owns other energy drink brands, such as Reign, NOS, Burn, Bang and Mother, and brews and distributes beers and flavored malt beverages following the acquisition of a craft brewer in 2022. Monster controls branding and innovation but outsources beverage manufacturing and packaging to copackers and finished goods distribution to bottlers in the global Coca-Cola system (pursuant to a 20-year agreement inked in 2015). Coke is the largest shareholder of Monster with a 19.5% stake.
In light of the recent options history for Monster Beverage, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Monster Beverage</h3>
<ul>
<li>With a volume of 3,825,762, the price of MNST is down -0.04% at $51.63. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 0 days.</li>
</ul>
<h3>What Analysts Are Saying About Monster Beverage</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $51.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Neutral rating for Monster Beverage, targeting a price of $51. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Monster Beverage with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

MNST

Monster Beverage's Options: A Look at What the Big Money is Thinking

Deep-pocketed investors have adopted a bullish approach towards Enovix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVX#NASDAQ">ENVX</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ENVX usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Enovix. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 55% leaning bullish and 44% bearish. Among these notable options, 4 are puts, totaling $379,224, and 5 are calls, amounting to $189,826.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $10.0 to $20.0 for Enovix over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of Enovix stands at 4880.62, with a total volume reaching 1,908.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Enovix, situated within the strike price corridor from $10.0 to $20.0, throughout the last 30 days.
<h3>Enovix Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740687365_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ENVX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$4.45</td>
<td>$4.35</td>
<td>$4.35</td>
<td>$13.00</td>
<td>$130.0K</td>
<td>521</td>
<td align="right">158</td>
</tr>
<tr>
<td>ENVX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$4.35</td>
<td>$4.25</td>
<td>$4.25</td>
<td>$13.00</td>
<td>$116.8K</td>
<td>1.1K</td>
<td align="right">1</td>
</tr>
<tr>
<td>ENVX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$3.55</td>
<td>$3.45</td>
<td>$3.45</td>
<td>$12.00</td>
<td>$103.1K</td>
<td>3.1K</td>
<td align="right">1</td>
</tr>
<tr>
<td>ENVX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/21/25</td>
<td>$2.66</td>
<td>$2.43</td>
<td>$2.43</td>
<td>$11.00</td>
<td>$44.2K</td>
<td>10</td>
<td align="right">227</td>
</tr>
<tr>
<td>ENVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.82</td>
<td>$1.58</td>
<td>$1.65</td>
<td>$17.00</td>
<td>$41.2K</td>
<td>25.9K</td>
<td align="right">250</td>
</tr>
</tbody>
</table>

<h3>About Enovix</h3>
Enovix Corp is engaged in the business of advanced silicon-anode lithium-ion battery development and production. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable the widespread utilization of renewable energy.
Having examined the options trading patterns of Enovix, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of Enovix</h3>
<ul>
<li>Currently trading with a volume of 3,156,434, the ENVX's price is down by -4.05%, now at $9.24. </li>
<li>RSI readings suggest the stock is currently may be oversold.</li>
<li>Anticipated earnings release is in 62 days.</li>
</ul>
<h3>Expert Opinions on Enovix</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $24.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $30. 
&#x2A; An analyst from Craig-Hallum persists with their Buy rating on Enovix, maintaining a target price of $18. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Enovix, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

ENVX

Enovix Unusual Options Activity For February 27

Deep-pocketed investors have adopted a bullish approach towards Lowe's Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in LOW usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 44 extraordinary options activities for Lowe's Companies. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 25% bearish. Among these notable options, 4 are puts, totaling $178,362, and 40 are calls, amounting to $1,638,225.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $110.0 to $300.0 for Lowe's Companies over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Lowe's Companies's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Lowe's Companies's whale trades within a strike price range from $110.0 to $300.0 in the last 30 days. 
<h3>Lowe's Companies 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740687360_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$139.6</td>
<td>$138.4</td>
<td>$139.28</td>
<td>$110.00</td>
<td>$55.7K</td>
<td>19</td>
<td align="right">16</td>
</tr>
<tr>
<td>LOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$139.0</td>
<td>$137.5</td>
<td>$138.53</td>
<td>$110.00</td>
<td>$55.4K</td>
<td>19</td>
<td align="right">80</td>
</tr>
<tr>
<td>LOW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$9.1</td>
<td>$9.05</td>
<td>$9.05</td>
<td>$240.00</td>
<td>$54.3K</td>
<td>1.6K</td>
<td align="right">109</td>
</tr>
<tr>
<td>LOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$9.5</td>
<td>$9.3</td>
<td>$9.3</td>
<td>$260.00</td>
<td>$48.3K</td>
<td>120</td>
<td align="right">0</td>
</tr>
<tr>
<td>LOW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/07/25</td>
<td>$0.8</td>
<td>$0.67</td>
<td>$0.7</td>
<td>$235.00</td>
<td>$48.2K</td>
<td>137</td>
<td align="right">958</td>
</tr>
</tbody>
</table>

<h3>About Lowe's Companies</h3>
Lowe's is the second-largest home improvement retailer in the world, operating more than 1,700 stores in the United States, after the 2023 divestiture of its Canadian locations (RONA, Lowe's Canada, Réno-Dépôt, and Dick's Lumber). The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's primarily targets retail do-it-yourself (around 70% of sales in 2024) and do-it-for-me customers, but has expanded its commercial and professional business clients to 30% from less than 20% in the past six years. We estimate Lowe's captures a high-single-digit share of the domestic home improvement market, based on US Census data and management's market size estimates.
<h3>Where Is Lowe's Companies Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 1,289,543, the LOW's price is down by -0.06%, now at $246.91. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 82 days.</li>
</ul>
<h3>What The Experts Say On Lowe's Companies</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $296.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Piper Sandler persists with their Overweight rating on Lowe's Companies, maintaining a target price of $296. 
&#x2A; An analyst from Truist Securities has decided to maintain their Buy rating on Lowe's Companies, which currently sits at a price target of $295. 
&#x2A; An analyst from Mizuho has decided to maintain their Outperform rating on Lowe's Companies, which currently sits at a price target of $300. 
&#x2A; An analyst from Telsey Advisory Group persists with their Outperform rating on Lowe's Companies, maintaining a target price of $305. 
&#x2A; An analyst from RBC Capital persists with their Sector Perform rating on Lowe's Companies, maintaining a target price of $285. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Lowe's Companies options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Lowe's Companies's Options: A Look at What the Big Money is Thinking

PACCAR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>) has outperformed the market over the past 5 years by 4.1% on an annualized basis producing an average annual return of 18.54%. Currently, PACCAR has a market capitalization of $55.32 billion. 
Buying $1000 In PCAR: If an investor had bought $1000 of PCAR stock 5 years ago, it would be worth $2,269.16 today based on a price of $105.41 for PCAR at the time of writing.
<h3>PACCAR's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740687308_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PCAR

Here's How Much You Would Have Made Owning PACCAR Stock In The Last 5 Years

Billionaire Elon Musk took social media platform Twitter, now known as X, private with a $44 billion acquisition that closed <a href="https://www.benzinga.com/news/23/04/31810229/elon-musk-bought-twitter-1-year-ago-a-look-back-at-whats-happened-since-and-what-could-be-next">in October 2022.</a>
With news of potential new financing and growth, Benzinga polled readers to see what they thought a fair valuation for X is today.
What Happened: X&#8217;s value declined after Musk bought it. The banks<a href="https://www.benzinga.com/25/01/43204045/elon-musk-says-x-user-growth-is-stagnant-banks-who-financed-acquisition-selling-debt-at-10-discount"> that helped finance </a>the buyout were stuck holding the debt obligations.
Those banks recently offloaded the majority of the debt at valuations discounted 10%, or near the amount Musk paid, according to <a href="https://www.bloomberg.com/news/articles/2025-02-19/musk-s-x-is-in-talks-to-raise-money-at-a-44-billion-valuation">Bloomberg</a>.
Musk is reportedly looking at raising additional funds for X at a $44 billion valuation, which could help pay down debt and finance new growth areas like video and payments.
Benzinga recently asked about what the valuation of the privately held company should be.
"What do you believe is a fair valuation for X (formerly Twitter)?" Benzinga asked.
The results were:
<ul>
<li>Less than $20 Billion: 45%</li>
<li>$41-$75 Billion: 24%</li>
<li>Over $75 Billion: 16%</li>
<li>$21-$40 Billion: 15%</li>
</ul>
Nearly half of the voters in the poll said X should be valued at less than $20 billion, which would represent a valuation of less than half of what Musk paid for the company back in 2022.
The next highest vote-getter was the $41 to $75 billion range at 24%. Over $75 billion ranked third at 16%. This means that 40% of voters think X should be valued at $41 billion or more.
While that's good news, the majority (60%) see X valuation fairly valued at $40 billion or less today.
Are you buying when the CEOs of the Magnificent 7 are selling?
<ul>
<li>Stay in the know with our Insider Trades page — <a href="https://www.benzinga.com/sec/insider-trades/">see when leaders like Mark Zuckerberg, Elon Musk, and Jensen Huang are offloading their own shares.</a></li>
</ul>
Why It's Important: Since Musk took over Twitter, the social media company has struggled to have a high private valuation.
The company immediately discounted the valuation with stock awards for employees valuing the company at $20 billion.
Fidelity, who owns a stake in the company, has been<a href="https://www.benzinga.com/24/12/42271676/fidelity-raises-valuation-of-elon-musks-x-but-its-still-worth-72-less-than-his-buyout-price"> discounting its carrying value</a> of the company. In December, Fidelity valued X at $12.3 billion, or down 72% from its original buyout price.
Companies associated with Musk have witnessed increased valuations since the 2024 election thanks to the billionaire's close relationship with President Donald Trump. SpaceX, xAI and Tesla saw higher valuations to close out 2024 and in early 2025.
Musk recently said X<a href="https://www.benzinga.com/news/24/11/41766191/elon-musk-says-x-saw-record-usage-on-election-day-as-trump-closes-in-on-white-house-win" target="_blank" rel="noreferrer noopener">&nbsp;saw record usage&nbsp;</a>during the 2024 presidential election, but growth may be slowing into the new 2025 year.
A January email Musk sent to X staff highlighted his concerns for the company&#8217;s financial state.
&#8220;Our user growth is stagnant, revenue is unimpressive, and we&#8217;re barely breaking even,&#8221; Musk said in an email, as&nbsp;<a href="https://www.wsj.com/finance/banking/wall-street-banks-prepare-to-sell-billions-of-dollars-of-x-loans-c609beb1?mod=e2tw" target="_blank" rel="noreferrer noopener">seen&nbsp;</a>by The Wall Street Journal.
While Musk was unimpressed with the financial state of X, the comment of breaking even comes after years of losses for the social media company. Musk highlighted the rising influence X has in the same email.
&#8220;Over the last few months, we&#8217;ve witnessed the power of X in shaping national conversations and outcomes. We are also seeing other platforms begin to adopt our commitment to free speech and unbiased truth.&#8221;
With the potential that X&#8217;s financials have stabled with break-even earnings along with Musk&#8217;s friendship with Trump, banks could see this as the perfect time to sell off unwanted debt in X.
The report said that some investors have reached out to banks with interest in buying up debt in X due to the improving financials and public image.
X could see an improving financial situation and rise in valuation in 2025 with the <a href="https://www.benzinga.com/general/social-media/25/01/43373012/elon-musk-bringing-advertisers-back-to-x-amazon-boosts-spending-apple-considers-return">return of advertisers</a> to the platform and the pending launch of a payments platform.
Musk <a href="https://www.benzinga.com/m-a/22/10/29334819/elon-musk-sees-long-term-potential-in-twitter-despite-obviously-overpaying-for-it">previously shared optimism </a>for X and its future valuation.
&#8220;I see a clear, but difficult, path to a &lt;$250B valuation,&#8221; Musk said previously.
Benzinga readers don't see the valuation of X there yet, but perhaps someday Musk will be proven right.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/politics/25/02/43880789/elon-musk-approval-rating-hits-41-voters-not-impressed-with-doge-work-and-calls-to-eliminate-departments">Elon Musk Approval Rating Hits 41%: Voters Not Impressed With DOGE Work And Calls To Eliminate Departments</a></li>
</ul>
The study was conducted by Benzinga from Feb. 19, 2025 through Feb. 21, 2025. It included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 98 adults.

Comments

VanEck Fabless Semiconductor ETF

ニュース

最新ニュース VanEck Fabless Semiconductor ETF (NASDAQ:SMHX)

ニュース

パートナーシップ

ベンジンガ・グローバル